Orchid Pharma Ltd.

Financial

	Orchid Pharma	Natco Pharma	Concord Biotech
Operational Metrics
Financials
5 yr Average ROE	-7.68 %	12.01 %	19.98 %
5yr average Equity Multiplier	0.59	1.19	1.34
5yr Average Asset Turnover Ratio	0.38	0.44	0.48
5yr Avg Net Profit Margin	-6.96 %	22.3 %	30.93 %
Price to Book	4.97	3.49	12.8
P/E	46.71	14.46	72.22
5yr Avg Cash Conversion Cycle	49.91 Days	55.67 Days	7.8 Days
Inventory Days	112.74 Days	103.24 Days	81.4 Days
Days Receivable	105.72 Days	93.53 Days	103.56 Days
Days Payable	255.1 Days	180.2 Days	178.94 Days
5yr Average Interest Coverage Ratio	0.47	37.72	139.29
5yr Avg ROCE	-4.58 %	15.05 %	25.38 %
5yr Avg Operating Profit Margin	10.74 %	34.37 %	47.04 %
5 yr average Debt to Equity	-0.45	0.07	0.06
5yr CAGR Net Profit	-7.77 %	2.11 %	7.28 %
5yr Average Return on Assets	-2.51 %	10.04 %	14.95 %
Shareholdings
Promoter Holding	69.84 %	49.71 %	44.08 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-28.23 %	0.84 %	0.0
Change in Mutual Fund Holding (3 Yrs)	15.18 %	-5.37 %	-0.43 %

Business

	Orchid Pharma	Natco Pharma	Concord Biotech
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 68.28 Sterile 31.72 Crop Health 0 API(Domestic & Exports) 0 Formulation 0 Formulations 0 API - Fermentation based 0	Product Wise Break-Up Formulations 88.61 Crop Protection 1.77 Sterile 0 API - Fermentation based 0 Formulations 0 Active Pharmaceutical Ingredient (API) 5.82 Oral Formulations 0 Others 3.8	Product Wise Break-Up Formulation 0 Crop Health 0 Sterile 0 API - Fermentation based 71.55 Formulations 28.45 API(Domestic & Exports) 0 Oral Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 15.85 Rest of the World 0 USA 0 Others 84.15	Location Wise Break-Up USA 59.55 Rest of the World 22.23 India 18.22	Location Wise Break-Up USA 0 Rest of the World 53.53 India 46.47
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-